182 related articles for article (PubMed ID: 33350744)
1. Incidence and severity of adverse events among platelet donors: A three-year retrospective study.
Almutairi H; Salam M; Batarfi K; Alharbi D; Wani F; Almutairi A; Al-Shammari B; Al-Surimi K
Medicine (Baltimore); 2020 Dec; 99(52):e23648. PubMed ID: 33350744
[TBL] [Abstract][Full Text] [Related]
2. Clinical Indications and Adverse Reactions of Platelet Apheresis.
Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
[TBL] [Abstract][Full Text] [Related]
3. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
Patidar GK; Sharma RR; Marwaha N
Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
[TBL] [Abstract][Full Text] [Related]
4. Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program.
Despotis GJ; Goodnough LT; Dynis M; Baorto D; Spitznagel E
Vox Sang; 1999; 77(1):24-32. PubMed ID: 10474087
[TBL] [Abstract][Full Text] [Related]
5. Donor complication rates in whole blood, plasma and platelet donors: Age versus experience.
Paalvast Y; Díaz Padilla N; Bruijns S; Wiersum-Osselton J; Molenaar T
Transfusion; 2024 May; 64(5):854-865. PubMed ID: 38385649
[TBL] [Abstract][Full Text] [Related]
6. Incidence, predictors and severity of adverse events among whole blood donors.
Almutairi H; Salam M; Alajlan A; Wani F; Al-Shammari B; Al-Surimi K
PLoS One; 2017; 12(7):e0179831. PubMed ID: 28732090
[TBL] [Abstract][Full Text] [Related]
7. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
[TBL] [Abstract][Full Text] [Related]
8. The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis.
de Farias CLG; Bassolli L; Mendrone-Junior A; de Araújo Arrais C; Duran A; Rocha V; de Almeida-Neto C
Transfus Apher Sci; 2022 Aug; 61(4):103424. PubMed ID: 35346602
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for complications in donors at first and repeat whole blood donation: a cohort study with assessment of the impact on donor return.
Wiersum-Osselton JC; Marijt-van der Kreek T; Brand A; Veldhuizen I; van der Bom JG; de Kort W
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s28-36. PubMed ID: 23867173
[TBL] [Abstract][Full Text] [Related]
10. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.
Crocco I; Franchini M; Garozzo G; Gandini AR; Gandini G; Bonomo P; Aprili G
Blood Transfus; 2009 Jan; 7(1):35-8. PubMed ID: 19290078
[TBL] [Abstract][Full Text] [Related]
11. Total platelet donation count and donation frequency are determinants of plateletpheresis-associated lymphopenia.
Thuer L; Brosig A; Hutchinson JA; Hähnel V; Offner R; Burkhardt R; Ahrens N
Transfusion; 2021 Nov; 61(11):3161-3173. PubMed ID: 34545947
[TBL] [Abstract][Full Text] [Related]
12. Adverse reactions in whole blood donors: an Indian scenario.
Pathak C; Pujani M; Pahuja S; Jain M
Blood Transfus; 2011 Jan; 9(1):46-9. PubMed ID: 21084010
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and factors associated with vasovagal reaction among whole blood donors in hospital Universiti Sains Malaysia.
Ibrahim NN; Mohd Noor NH; Zulkafli Z
Transfus Clin Biol; 2023 May; 30(2):238-243. PubMed ID: 36702200
[TBL] [Abstract][Full Text] [Related]
14. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events.
Thijsen A; Davison TE; Speedy J; Hoad V; Masser B
Vox Sang; 2021 Mar; 116(3):273-280. PubMed ID: 32702163
[TBL] [Abstract][Full Text] [Related]
15. A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse.
Trouern-Trend JJ; Cable RG; Badon SJ; Newman BH; Popovsky MA
Transfusion; 1999 Mar; 39(3):316-20. PubMed ID: 10204597
[TBL] [Abstract][Full Text] [Related]
16. Vasovagal reactions in blood donors during or immediately after blood donation.
Zervou EK; Ziciadis K; Karabini F; Xanthi E; Chrisostomou E; Tzolou A
Transfus Med; 2005 Oct; 15(5):389-94. PubMed ID: 16202053
[TBL] [Abstract][Full Text] [Related]
17. Case-control study of immediate and delayed vasovagal reactions in blood donors.
Narbey D; Fillet AM; Jbilou S; Tiberghien P; Djoudi R
Vox Sang; 2016 Oct; 111(3):257-265. PubMed ID: 27232998
[TBL] [Abstract][Full Text] [Related]
18. [Delayed adverse reactions to blood donation: From haemovigilance data to specific studies].
Py JY; Durieux S; Barnoux M; Sapey T
Transfus Clin Biol; 2016 Nov; 23(4):233-239. PubMed ID: 27769684
[TBL] [Abstract][Full Text] [Related]
19. First-time whole blood donation: A critical step for donor safety and retention on first three donations.
Gillet P; Rapaille A; Benoît A; Ceinos M; Bertrand O; de Bouyalsky I; Govaerts B; Lambermont M
Transfus Clin Biol; 2015; 22(5-6):312-7. PubMed ID: 26476508
[TBL] [Abstract][Full Text] [Related]
20. Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study.
Zhao J; Gabriel E; Norda R; Höglund P; Baden L; Diedrich BA; Marits P; Enoksson SL; Gansner JM; Kaufman R; Dickman PW; Edgren G
Transfusion; 2021 Feb; 61(2):464-473. PubMed ID: 33186486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
